×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

South Korea Biomaterial Market

ID: MRFR/HC/48462-HCR
200 Pages
Garvit Vyas
October 2025

South Korea Biomaterial Market Research Report By Application (Medical Devices, Tissue Engineering, Drug Delivery, Orthopedics, Wound Care), By Type (Natural Biomaterials, Synthetic Biomaterials, Modified Biomaterials), By Source (Plant-based, Animal-based, Microbial-based) andBy End Use (Healthcare, Pharmaceuticals, Cosmetics)- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

South Korea Biomaterial Market Infographic
Purchase Options

South Korea Biomaterial Market Summary

As per MRFR analysis, the South Korea biomaterial market Size was estimated at 2500.0 USD Million in 2024. The South Korea biomaterial market is projected to grow from 2662.5 USD Million in 2025 to 5000.0 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 6.5% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The South Korea biomaterial market is experiencing robust growth driven by sustainability and innovation.

  • Sustainable packaging solutions are gaining traction as consumers increasingly prefer eco-friendly products.
  • Advancements in material science are enhancing the performance and applicability of biomaterials across various sectors.
  • The healthcare segment is the largest, while the packaging segment is the fastest-growing in the South Korea biomaterial market.
  • Rising demand for eco-friendly products and regulatory support for sustainable practices are key drivers propelling market growth.

Market Size & Forecast

2024 Market Size 2500.0 (USD Million)
2035 Market Size 5000.0 (USD Million)

Major Players

BASF SE (DE), DuPont de Nemours Inc (US), Covestro AG (DE), Mitsubishi Chemical Corporation (JP), Evonik Industries AG (DE), NatureWorks LLC (US), 3M Company (US), Futerro (BE)

South Korea Biomaterial Market Trends

The biomaterial market in South Korea is currently experiencing a notable transformation, driven by increasing environmental awareness and the demand for sustainable alternatives to traditional materials. This shift is largely influenced by government initiatives aimed at promoting eco-friendly practices and reducing reliance on fossil fuels. As a result, various industries, including packaging, automotive, and healthcare, are increasingly adopting biomaterials to meet regulatory requirements and consumer preferences. The emphasis on innovation in material science is also propelling the development of advanced biomaterials that offer enhanced performance and functionality. In addition, the South Korean government is actively supporting research and development in the biomaterial sector, which is likely to foster collaboration between academia and industry. This collaborative approach may lead to the emergence of new applications and technologies that could further expand the biomaterial market. Moreover, the growing trend of circular economy practices is encouraging companies to explore biodegradable and compostable materials, thereby reducing waste and promoting sustainability. Overall, the biomaterial market in South Korea appears poised for growth, driven by a combination of regulatory support, consumer demand, and technological advancements.

Sustainable Packaging Solutions

The demand for sustainable packaging solutions is rising within the biomaterial market. Companies are increasingly seeking biodegradable and compostable materials to reduce environmental impact. This trend aligns with consumer preferences for eco-friendly products, prompting manufacturers to innovate and develop new packaging options that meet sustainability criteria.

Advancements in Material Science

Innovations in material science are significantly influencing the biomaterial market. Research institutions and companies are collaborating to create advanced biomaterials with improved properties. These developments may lead to enhanced performance in various applications, including medical devices and construction materials, thereby expanding market opportunities.

Government Support and Regulation

Government initiatives and regulations are playing a crucial role in shaping the biomaterial market. Policies promoting the use of sustainable materials and providing funding for research are encouraging industry growth. This support may facilitate the transition towards more environmentally friendly practices across multiple sectors.

South Korea Biomaterial Market Drivers

Growing Applications in Healthcare

The healthcare sector is increasingly adopting biomaterials for various applications, which is propelling the growth of the biomaterial market. In South Korea, the demand for biocompatible materials for medical devices, implants, and drug delivery systems is on the rise. This trend is driven by the need for safer and more effective medical solutions. The biomaterial market in healthcare is projected to grow significantly, with estimates suggesting a value of over $800 million by 2027. The integration of biomaterials in regenerative medicine and tissue engineering is particularly noteworthy, as it opens new avenues for treatment and recovery. Consequently, the healthcare industry's reliance on biomaterials is likely to enhance the overall market dynamics.

Rising Demand for Eco-Friendly Products

The increasing consumer awareness regarding environmental sustainability is driving the demand for eco-friendly products in the biomaterial market. In South Korea, consumers are becoming more conscious of the ecological impact of their purchases, leading to a shift towards biodegradable and renewable materials. This trend is reflected in the growth of the biomaterial market, which is projected to reach approximately $1.5 billion by 2026. Companies are responding by innovating and developing new biomaterials that align with consumer preferences for sustainability. This shift not only enhances brand loyalty but also positions companies favorably in a competitive market. As a result, the biomaterial market is likely to experience robust growth fueled by this rising demand for environmentally friendly alternatives.

Technological Innovations in Biomaterials

Technological advancements play a crucial role in shaping the biomaterial market in South Korea. Innovations in material science, such as the development of new biopolymers and composites, are enhancing the performance and applicability of biomaterials across various industries. For instance, the integration of nanotechnology in biomaterials is leading to improved mechanical properties and functionality. The South Korean biomaterial market is expected to witness a compound annual growth rate (CAGR) of around 12% over the next five years, driven by these technological innovations. Companies investing in research and development are likely to gain a competitive edge, as they can offer superior products that meet the evolving needs of consumers and industries alike.

Regulatory Support for Sustainable Practices

Regulatory frameworks in South Korea are increasingly favoring sustainable practices, which is positively impacting the biomaterial market. The government is implementing policies that encourage the use of biodegradable materials and reduce reliance on conventional plastics. These regulations are designed to promote environmental sustainability and align with global trends towards greener alternatives. As a result, companies in the biomaterial market are adapting their strategies to comply with these regulations while also capitalizing on the opportunities they present. The anticipated growth in the biomaterial market is likely to be bolstered by these supportive regulatory measures, which aim to foster innovation and sustainability in material usage.

Increased Investment in Research and Development

Investment in research and development (R&D) is a significant driver of growth in the biomaterial market. In South Korea, both public and private sectors are allocating substantial funds to explore new biomaterials and their applications. This focus on R&D is essential for fostering innovation and enhancing the competitiveness of the biomaterial market. For instance, government initiatives have been established to support startups and established companies in developing advanced biomaterials. The South Korean government has earmarked approximately $200 million for R&D in sustainable materials over the next few years. Such investments are likely to accelerate the pace of innovation and contribute to the overall expansion of the biomaterial market.

Market Segment Insights

Biomaterial Market Application Insights

The South Korea Biomaterial Market is strategically segmented into various applications that play a vital role in enhancing healthcare outcomes. A significant driver in this market is the Medical Devices sector, which leverages advanced biomaterials for products such as implants, surgical instruments, and diagnostics. The medical device market's penetration is largely fueled by the country's robust healthcare infrastructure and continued investments in Research and Development, alongside rising demand for minimally invasive procedures.

Tissue Engineering is another pivotal application, focusing on the development of biocompatible scaffolds that support cell growth and tissue regeneration. This segment garners attention due to the increasing prevalence of chronic diseases and advancements in regenerative medicine, which promote the use of engineered tissues for repair. With an aging population in South Korea, the need for effective solutions in tissue repair and replacement is becoming more pronounced. Drug Delivery is rapidly evolving within the South Korea Biomaterial Market, offering innovative solutions to enhance the efficacy and safety of pharmaceuticals.

This application uses biomaterials to facilitate controlled release mechanisms, allowing for sustained therapeutic effects while minimizing side effects. The demand for targeted therapy is elevating the importance of this segment, as it aligns with advancements in personalized medicine and the quest for more effective treatment methodologies.

Additionally, Orthopedics constitutes a significant part of the biomaterials applications, primarily focusing on joint replacements and bone repair materials, which are essential given the rising incidents of orthopedic diseases and injuries. This area is supported by extensive clinical research and the development of biocompatible materials that promote faster healing and restore functionality. Wound Care, facilitated by the use of hydrogels and other advanced biomaterials, is a noteworthy application addressing the growing prevalence of chronic wounds and the medical needs associated with them.

The increasing incidences of diabetes and the associated risk of diabetic ulcers further heighten the need for advanced wound care solutions. These products not only accelerate healing but also reduce the risk of infections, making them crucial in both clinical and home healthcare settings. Overall, the diverse applications within the South Korea Biomaterial Market reflect a landscape driven by innovation and the urgent need for improved health solutions, critical to addressing the evolving healthcare challenges faced by the population.

Biomaterial Market Type Insights

The South Korea Biomaterial Market is segmented into various types, including Natural Biomaterials, Synthetic Biomaterials, and Modified Biomaterials, each contributing significantly to the market dynamics. Natural Biomaterials, derived from renewable resources, are gaining traction due to their biodegradability and compatibility with human tissues, making them ideal for applications in tissue engineering and regenerative medicine. Synthetic Biomaterials, often engineered for specific functionalities, offer advantages such as uniformity and controlled properties, thus catering to a wide range of medical applications including implants and drug delivery systems.

Modified Biomaterials combine the inherent qualities of natural and synthetic materials to enhance performance and functionality, making them highly sought after in advanced biomedical applications. The growing demand for biocompatible and sustainable materials in the healthcare sector, alongside increasing Research and Development initiatives, propels the South Korea Biomaterial Market forward. As the nation invests heavily in healthcare innovation and sustainable practices, each of these segments addresses unique needs, driving further advancements and opportunities within the industry. The continual evolution in design and application of these materials reflects the shifting focus toward sustainable healthcare solutions in South Korea.

Biomaterial Market Source Insights

The South Korea Biomaterial Market is significantly influenced by the Source segment, which includes Plant-based, Animal-based, and Microbial-based materials. The rising environmental concerns and the push for sustainable products have led to a considerable focus on Plant-based biomaterials, which are lauded for their renewable characteristics and biodegradability, catering to various industries like packaging, textiles, and construction. On the other hand, Animal-based biomaterials are essential in medical applications, particularly in tissue engineering and regenerative medicine, providing natural compatibility with biological systems.

Furthermore, Microbial-based biomaterials are gaining traction due to their potential in producing high-value biopolymers and bioplastics, driving innovation in food and pharmaceuticals. The diversity in sources enhances the overall resilience of the South Korea Biomaterial Market by providing alternatives that can adapt to changing consumer preferences and regulatory environments, thereby ensuring market growth and diversification. Changes in consumer awareness and advancements in technology continue to reshape these segments, presenting both challenges and opportunities for stakeholders within the South Korea Biomaterial Market industry.

Biomaterial Market End Use Insights

The South Korea Biomaterial Market is witnessing notable growth across various end-use applications, emphasizing its significance in the Healthcare, Pharmaceuticals, and Cosmetics sectors. The Healthcare sector stands out as a major driving force, where the demand for biocompatible materials is essential for medical devices, surgical implants, and tissue engineering. This sector's growth is supported by advances in medical technology and an increasing aging population in South Korea, which heightens the need for effective medical solutions. Pharmaceuticals, another crucial segment, benefits from biomaterials used in drug delivery systems and excipients, enhancing the efficacy and safety of medications.

Meanwhile, the Cosmetics sector represents a growing area where natural and biodegradable materials are sought after for skincare and personal care products, addressing consumer inclination towards sustainable beauty products. Overall, these segments reflect strong growth potential, driven by innovation, regulations promoting biobased materials, and a shift towards sustainable practices in South Korea, collectively shaping the future landscape of the South Korea Biomaterial Market.

Get more detailed insights about South Korea Biomaterial Market

Key Players and Competitive Insights

The biomaterial market in South Korea is characterized by a dynamic competitive landscape, driven by increasing demand for sustainable materials and innovative applications across various industries. Key players such as BASF SE (DE), DuPont de Nemours Inc (US), and Covestro AG (DE) are strategically positioned to leverage their extensive research and development capabilities. These companies focus on innovation and sustainability, which are critical in shaping the competitive environment. Their operational strategies often include partnerships and collaborations aimed at enhancing product offerings and expanding market reach, thereby fostering a more competitive atmosphere.

In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain efficiency. This approach is particularly relevant in a moderately fragmented market where several players vie for market share. The collective influence of major companies like Mitsubishi Chemical Corporation (JP) and Evonik Industries AG (DE) contributes to a competitive structure that encourages innovation while also addressing regional market needs.

In October 2025, BASF SE (DE) announced a partnership with a local South Korean firm to develop biodegradable plastics tailored for the Asian market. This strategic move underscores BASF's commitment to sustainability and its intent to capitalize on the growing demand for eco-friendly materials in the region. By aligning with local expertise, BASF aims to enhance its product development capabilities and strengthen its market position.

In September 2025, DuPont de Nemours Inc (US) launched a new line of biopolymers designed for use in the automotive sector, emphasizing lightweight and sustainable materials. This initiative reflects DuPont's focus on innovation and its strategy to penetrate high-growth sectors. The introduction of these biopolymers is likely to attract automotive manufacturers seeking to meet stringent environmental regulations while enhancing performance.

In August 2025, Covestro AG (DE) expanded its production capacity for bio-based polycarbonate materials in South Korea. This expansion is indicative of Covestro's strategy to meet the rising demand for sustainable materials in various applications, including electronics and automotive. By increasing production capacity, Covestro positions itself to capture a larger share of the market while reinforcing its commitment to sustainability.

As of November 2025, current trends in the biomaterial market are heavily influenced by digitalization, sustainability, and the integration of AI technologies. Strategic alliances among key players are shaping the competitive landscape, fostering innovation and collaboration. The shift from price-based competition to a focus on technological advancement and supply chain reliability is evident. Companies are likely to differentiate themselves through innovative solutions and sustainable practices, which will be crucial for maintaining a competitive edge in the evolving market.

Key Companies in the South Korea Biomaterial Market market include

Industry Developments

In recent months, the South Korea Biomaterial Market has seen notable developments, particularly with companies like SK Innovation and LG Chem enhancing their commitment to sustainable materials. The South Korean government is actively supporting green technologies, leading to increased funding for Research and Development initiatives in biomaterials. In September 2023, Toray Industries announced advancements in biodegradable polymers, furthering the country's efforts towards eco-friendly solutions. Mergers and acquisitions have been significant, with BASF completing the acquisition of a minority stake in a local biocomposite project in August 2023, indicating a growing interest in sustainable materials.

Additionally, SABIC has expanded its bio-based product offerings in South Korea, boosting market presence. Over the last couple of years, demand for bio-based plastics has surged, spurred by increasing environmental regulations and consumer awareness, with companies like Hanwha Solutions investing heavily to expand production capacity. Asahi Kasei's focus on innovative biomaterials has also positioned it favorably in the market. Overall, the South Korean Biomaterial Market is experiencing notable growth, driven by technological innovations and strategic partnerships, reflecting a broad shift towards sustainability within the industry.

Future Outlook

South Korea Biomaterial Market Future Outlook

The biomaterial market in South Korea is projected to grow at a 6.5% CAGR from 2024 to 2035, driven by advancements in sustainable materials and increasing healthcare applications.

New opportunities lie in:

  • Development of biodegradable packaging solutions for consumer goods.
  • Investment in R&D for innovative medical implants using biomaterials.
  • Expansion of biocomposite materials in construction for eco-friendly building solutions.

By 2035, the biomaterial market is expected to achieve substantial growth and innovation.

Market Segmentation

South Korea Biomaterial Market Type Outlook

  • Natural Biomaterials
  • Synthetic Biomaterials
  • Modified Biomaterials

South Korea Biomaterial Market Source Outlook

  • Plant-based
  • Animal-based
  • Microbial-based

South Korea Biomaterial Market End-use Outlook

  • Healthcare
  • Pharmaceuticals
  • Cosmetics

South Korea Biomaterial Market Application Outlook

  • Medical Devices
  • Tissue Engineering
  • Drug Delivery
  • Orthopedics
  • Wound Care

Report Scope

MARKET SIZE 2024 2500.0(USD Million)
MARKET SIZE 2025 2662.5(USD Million)
MARKET SIZE 2035 5000.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 6.5% (2024 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled BASF SE (DE), DuPont de Nemours Inc (US), Covestro AG (DE), Mitsubishi Chemical Corporation (JP), Evonik Industries AG (DE), NatureWorks LLC (US), 3M Company (US), Futerro (BE)
Segments Covered Application, Type, Source, End-use
Key Market Opportunities Growing demand for sustainable packaging solutions drives innovation in the biomaterial market.
Key Market Dynamics Rising demand for sustainable materials drives innovation and competition in the biomaterial market.
Countries Covered South Korea

Leave a Comment

FAQs

What is the expected market size of the South Korea Biomaterial Market in 2024?

The South Korea Biomaterial Market is expected to be valued at 1.55 billion USD in 2024.

What is the projected market size of the South Korea Biomaterial Market by 2035?

By 2035, the South Korea Biomaterial Market is projected to reach a value of 3.1 billion USD.

What is the expected compound annual growth rate (CAGR) for the South Korea Biomaterial Market from 2025 to 2035?

The South Korea Biomaterial Market is expected to grow at a CAGR of 6.504% from 2025 to 2035.

Which application segment holds the largest market share in the South Korea Biomaterial Market?

The Medical Devices segment holds the largest market share, valued at 0.62 billion USD in 2024.

What is the market value for Tissue Engineering in the South Korea Biomaterial Market in 2024?

The Tissue Engineering segment is valued at 0.35 billion USD in 2024 within the South Korea Biomaterial Market.

Who are the key players in the South Korea Biomaterial Market?

Major players include SK Innovation, Hanwha Solutions, and BASF among others.

What is the expected market value for Drug Delivery by 2035 in the South Korea Biomaterial Market?

The Drug Delivery segment is expected to be valued at 0.55 billion USD by 2035.

What growth opportunities are present in the South Korea Biomaterial Market?

There are significant growth opportunities in medical devices and tissue engineering applications.

How is the South Korea Biomaterial Market expected to evolve by 2035?

By 2035, the Biomaterial Market in South Korea is anticipated to significantly expand, driven by advancements in technology and growing demand.

What is the projected value of the Wound Care segment in the South Korea Biomaterial Market in 2035?

The Wound Care segment is projected to be valued at 0.18 billion USD in 2035.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions